Newly FDA-Authorized Diabetes Digital Therapeutic Can be Cost-Effective, According to Modeling Study.Published in:Patient Care (Online), 2024, p. 1By:Myshko, DenisePublication type:Article
Newly FDA-Authorized Diabetes Digital Therapeutic Can be Cost-Effective, According to Modeling Study.Published in:Patient Care (Online), 2024, p. 1By:Myshko, DenisePublication type:Article
Lexicon Receives Complete Response Letter for Sotagliflozin in Type 1 Diabetes and Chronic Kidney Disease.Published in:Patient Care (Online), 2025, p. 5By:Myshko, DenisePublication type:Article
FDA Clears Phase 2 Study of Cannabis for PTSD Treatment in Veterans.Published in:Patient Care (Online), 2024, p. 5By:Myshko, DenisePublication type:Article
More than One-Third of US Adults Say They "Don't Need" Respiratory Virus Vaccines this Fall.Published in:Patient Care (Online), 2024, p. 1By:Myshko, DenisePublication type:Article